1. Home
  2. Press release
May, 09 2019 12:33 JST

Source: Eisai

Eisai and Allm Enter Into Capital and Business Alliance Agreement for ICT Healthcare Solutions


TOKYO, May, 09 2019 - (JCN Newswire) - Eisai Co., Ltd. and Allm Inc. have entered into a capital and business alliance agreement for ICT digital health solutions in various areas as well as regional medical treatment and care. Under this capital and business alliance, the two companies will collaborate on information provision to patients and healthcare professionals as well as development and provision of digital health solutions in regional medical treatment cooperation and comprehensive community care by extensively utilizing Allm's ICT systems for medical treatment and care. By applying Allm's experience in medical ICT systems to the "Dementia Ecosystem" that Eisai aims to establish, the two companies will thoroughly promote the utilization of IoT, big data and AI technologies in the health care area and provide new value for patients under the Fourth Industrial Revolution.

In its medium-term business plan EWAY2025, Eisai is aiming to become a "Medico Societal Innovator" (a company that changes society through creating medicines and providing solutions), promoting various kinds of digitalization such as the analysis of big data including real world data for the development of diagnostic methods and the provision of solutions in addition to creating next-generation treatment primarily in "neurology" and "oncology" that are Eisai's therapeutic areas of focus. Especially in the area of dementia, Eisai aims to establish the "Eisai Dementia Platform" by actively utilizing external big data and genomic data in addition to Eisai's own experience, know-how, and clinical data as well as build the "Dementia Ecosystem" by collaborating with partners such as other pharmaceutical companies, governments, medical organizations, care facilities, diagnostic developing companies, IT companies and insurance companies. Eisai thus aims to deliver novel benefits to patients with dementia and their families.

As "a company supporting all medicines (All Medical)", Allm upholds "Shaping Healthcare" as its corporate message, and provides services making contributions to the creation of global, social welfare design through IT technology. As a venture company specialized in medicine and healthcare, Allm is engaged in the development of programs for medical devices and provides "Team" comprehensive community care application and "MySOS" personal health record app. Currently operating in 12 countries, the company internationally provides approximately 1,700 medical/nursing institutions with ICT systems for medicine and nursing. In particular, the "Join" communication app for communication among healthcare professionals has become Japan's first medical device program which was made eligible for national health insurance by the Central Social Insurance Medical Council of the Japanese Ministry of Heath, Labor and Welfare.

Through these efforts to coordinate on the provision of healthcare solutions using ICT and the establishment of ecosystems in the area of dementia and others, Eisai and Allm are working to solve issues in regional medical treatment and care, and therefore contribution to the realization of well-being.

About Allm Inc.

As a "company supporting all medicines (All Medical)" upholding "Shaping Healthcare" as its corporate message, Allm provides mobile ICT solutions in the area of medicine and welfare. The company also proactively approaches global deployment of medical ICT business including the "Join" app for communication among healthcare professionals, providing solutions in 12 countries as a Japanese medical ICT company.

For more information about Allm Inc., please visit https://www.allm.net.


About Eisai
Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," which we call our human health care (hhc) philosophy. With approximately 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our hhc philosophy by delivering innovative products in various therapeutic areas with high unmet medical needs, including Neurology and Oncology.

In its medium-term business plan EWAY2025, Eisai is aiming to become a "Medico Societal Innovator" (a company that changes society through creating medicines and providing solutions), and is working on establishment of ecosystem platform business utilizing various data such as a large amount of clinical data, experiences, and know-how.

For more information about Eisai Co., Ltd., please visit https://www.eisai.co.jp.


Contact:
Allm Inc.
Group Strategy Office 
Tel：03-6418-3010

Eisai Co., Ltd.
Public Relations Department 
Tel：03-3817-5120
Source: Eisai
Sectors: BioTech

Copyright ©2019 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Related Press Release

Eisai's New Drug Approval for Fycompa for Adjunctive Treatment of Partial Onset Seizures in China
October 15 2019 20:24 JST
 
Eisai: Final Study Results Evaluating LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination Treatment in Advanced Endometrial Cancer Presented at ESMO 2019 Congress
October 01 2019 10:46 JST
 
Eisai and Nichi-Iko Enter into Collaboration Agreement for Generic Pharmaceutical Business in China
September 30 2019 11:06 JST
 
Eisai and Tokio Marine Nichido Enter Into Business Alliance for Co-Existence and Prevention of Dementia
September 26 2019 13:21 JST
 
Eisai and Fronteo to Launch Coroban Tumbling and Falling Prediction System for Inpatients
September 26 2019 13:08 JST
 
Eisai to Present Abstracts on Oncology Products and Pipeline at ESMO 2019 Congress
September 24 2019 09:01 JST
 
Eisai and Meiji Announce Parkinson's Disease Treatment Equfina Tablets (Safinamide Mesilate) Approved In Japan
September 20 2019 15:13 JST
 
Eisai's Promotion and Distribution Agreement with Mylan India for Eribulin Second Brand in India
September 20 2019 08:40 JST
 
Eisai to Present Latest Data on Lemborexant at World Sleep Congress
September 19 2019 19:06 JST
 
Eisai Selected for Membership in Dow Jones Sustainability Asia Pacific Index 2019
September 18 2019 20:40 JST
 
More Press release >>

Latest Press Release


Hitachi: Company Split of the Analysis Contract Service Business and the Transfer of Stock of the New Company
Oct 21, 2019 18:10 JST

Toyota Yaris WRC Set for Crucial Mixed-surface Spectacular
Oct 18, 2019 17:37 JST

Overview of Honda Exhibits at the 26th ITS World Congress 2019 in Singapore
Oct 18, 2019 15:46 JST

Hitachi Automotive Systems Starts Mass Production of High Voltage and High Output EV Inverter, the First in the World
Oct 18, 2019 15:33 JST

Hitachi Launches Dashboard for Building Owners and Managers to Check the Operation and Maintenance Status of Building Facilities, Including Elevators
Oct 18, 2019 09:03 JST

Toyota to Show Production-Ready Ultra-Compact BEV at 2019 Tokyo Motor Show "FUTURE EXPO"
Oct 17, 2019 13:48 JST

Monumental Sports & Entertainment, NEC Announce Partnership with Washington Wizards
Oct 16, 2019 17:45 JST

NEC Announces First International Partnership with Professional Basketball Player Rui Hachimura
Oct 16, 2019 17:33 JST

Hitachi and Frasers Property Sign S$100 Million MOU to Drive Digital Transformation in the Real Estate Industry in Asia Pacific
Oct 16, 2019 16:02 JST

Toyota's New Model Yaris Makes World Premiere
Oct 16, 2019 15:32 JST

Ministry of Movement and NEC to Collaborate on Future of Urban Mobility
Oct 16, 2019 15:04 JST

Eisai's New Drug Approval for Fycompa for Adjunctive Treatment of Partial Onset Seizures in China
Oct 15, 2019 21:24 JST

Fujitsu's Gymnastics Judging Support System Wins the "Minister of Internal Affairs and Communications Award" at CEATEC 2019
Oct 15, 2019 16:25 JST

Fujitsu Develops AI based Facial Expression Recognition Technology to Accurately Detect Subtle Changes in Expression
Oct 15, 2019 16:09 JST

Toyota Rolls Out New Compact Convertible Sports Car "Copen GR SPORT" in Japan
Oct 15, 2019 14:09 JST

Mazda Publishes Mazda Sustainability Report 2019 and Annual Report 2019
Oct 15, 2019 13:27 JST

Mazda Included in Dow Jones Sustainability Asia Pacific Index for Third Year Running
Oct 15, 2019 13:16 JST

Toyota: 'People of the Future' to Welcome Visitors at 'Mobility Theme Park'
Oct 11, 2019 16:14 JST

Toyota to Unveil Next-Generation "Mirai Concept" at 2019 Tokyo Motor Show's "Future Expo"
Oct 11, 2019 13:45 JST

Hitachi Expands Its Elevators & Escalators Business in Laos
Oct 10, 2019 19:53 JST
 More Latest Release >>